Ingredient or product comparison
Tissue Regeneration Outcomes: Collagen Deposition vs Cytokine Suppression
GHK-Cu's most documented effect is dose-dependent collagen synthesis enhancement. In a 12-week photoaging model using hairless mice, topical GHK-Cu at 0.5% concentration increased dermal collagen density by 42% versus vehicle controls, measured via hydroxyprol
This source-based comparison does not add ratings or recommend a winner.
- GHK-Cu's most documented effect is dose-dependent collagen synthesis enhancement. In a 12-week photoaging model using hairless mice, topical GHK-Cu at 0.5% concentration increased dermal collagen density by 42% versus vehicle controls, measured via hydroxyproline assay and confirmed histologically. The peptide also increased elastin fiber density by 23% and reduced MMP-1 expression. The enzyme responsible for collagen breakdown. By 38%. These effects scaled with copper availability: when dietary copper was restricted to marginal intake levels (0.8 mg/kg diet vs standard 6 mg/kg), GHK-Cu's collagen-stimulating effect dropped by approximately 60%, underscoring the cofactor dependency.
- KLOW demonstrates dose-dependent reduction in inflammatory markers without structural tissue remodeling. A 2024 study in the Archives of Dermatological Research tested KLOW in a UV-induced inflammation model: 100 micromolar KLOW applied topically reduced erythema scores by 35% and IL-1β levels by 50% at 48 hours post-exposure, but collagen density measurements showed no difference from controls at 4 or 8 weeks. The peptide effectively prevented inflammation-driven collagen degradation by blocking the inflammatory cascade upstream. But it did not stimulate new collagen synthesis once inflammation subsided.
- Here's the nuance that matters in research design: GHK-Cu can produce measurable increases in tissue thickness, tensile strength, and wound closure speed in models with active defects. KLOW preserves existing tissue by preventing inflammatory degradation but will not rebuild lost or aged extracellular matrix. If your endpoint is structural tissue improvement, GHK-Cu is the mechanistically appropriate choice. If the endpoint is prevention of inflammation-mediated damage, KLOW delivers that outcome without the metabolic cost of active tissue synthesis.